Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Solstice Advanced Materials Inc. Common Stock (SOLS) vs Welltower Inc. Common Stock (WELL) Price & Performance

Solstice Advanced Materials Inc. Common StockTrade
Welltower Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Solstice Advanced Materials Inc. Common Stock vs Welltower Inc. Common Stock — how do they compare? Solstice Advanced Materials Inc. Common Stock trades at $59.85 (market cap $9.55B), while Welltower Inc. Common Stock trades at $235.59 (market cap $167.30B). The key difference: Welltower Inc. Common Stock is far larger — about 17.5× Solstice Advanced Materials Inc. Common Stock's market cap, and Welltower Inc. Common Stock pays the higher dividend (1.46%). Which is the better fit depends on your goals — on Pluang, investors hold Solstice Advanced Materials Inc. Common Stock for 0 Days and Welltower Inc. Common Stock for 6 Days on average.

SOLSWELL
Market Cap
$9.55B$167.30B
Volume
2,661,2773,257,988
Sector
Basic MaterialsReal Estate
52-Week High
$88.60$252.07
52-Week Low
$41.43$172.08
Typical Hold Time
0 Days6 Days
Enterprise Value
$11.23B$185.05B
Dividend Yield
0.5%1.46%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Solstice Advanced Materials Inc. Common Stock

Solstice Advanced Materials (SOLS) trades at $60.91, up 0.33% with neutral technical signals. The company shows strong profitability with 30.64% gross margins and 14.95% ROE, though Q4 2025 earnings missed expectations. Recent developments include a $49M R&D expansion and termination of the Element Solutions merger, with the board authorizing a $500M share repurchase program. Analyst consensus is bullish with 80% buy ratings and a $80.22 price target representing 32% upside potential.

SOLS presents a compelling growth story with consistent earnings beats and institutional accumulation, though elevated P/E of 46.07 warrants caution. Key risks include execution challenges post-merger termination and margin pressure as profit margins declined from 6.09% to 5.12% year-over-year. The stock offers substantial upside if management delivers on growth initiatives while maintaining current profitability levels.

Welltower Inc. Common Stock

WELL trades at $230.14, down 0.07% on the day, with a bullish technical signal supported by moving averages and a strong ADX trend indicator. The stock shows mixed earnings performance, missing Q4 2025 and Q2 2026 EPS estimates but beating in Q1 2026. Revenue grew to $10.67B in 2025, with net income of $936.85M, and is projected to rise to $12.6B in 2026. Analyst sentiment is strongly positive, with 71.43% buy ratings and a consensus price target of $257.08, indicating potential upside. Recent news highlights strategic acquisitions and positive coverage on senior housing demand trends.

Outlook: WELL benefits from strong demographic tailwinds in senior housing and robust analyst support, but high valuation multiples and earnings volatility pose risks. The stock's current price near support at $226 suggests a cautious entry point, with upside driven by execution on growth projections and sector tailwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SOLS
100% Buy0% Sell
Avg holding period · 0 Days
WELL

No sentiment data available yet.

Top news

Latest headlines on both assets

About Solstice Advanced Materials Inc. Common Stock

Solstice Advanced Materials Inc. is a specialty materials company spun off from Honeywell in 2025, producing low-global-warming-potential refrigerants, blowing agents, and industrial solvents through its Refrigerants and Applied Solutions segment. Its Electronic and Specialty Materials segment supplies semiconductor materials, high-strength fibers, and healthcare-packaging films.

Read more on SOLS →

About Welltower Inc. Common Stock

Welltower is a real estate investment trust focused on healthcare properties. Its portfolio includes senior housing, outpatient medical facilities, and other health-related real estate.

Read more on WELL →